- Home
- CYBR vs HOLX Comparison
CYBR vs HOLX Comparison
Compare CYBR & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBR
- HOLX
- Stock Information
- Founded
- CYBR 1999
- HOLX 1985
- Country
- CYBR Israel
- HOLX United States
- Employees
- CYBR N/A
- HOLX N/A
- Industry
- CYBR Computer Software: Prepackaged Software
- HOLX Medical Electronics
- Sector
- CYBR Technology
- HOLX Health Care
- Exchange
- CYBR Nasdaq
- HOLX Nasdaq
- Market Cap
- CYBR 16.8B
- HOLX 16.7B
- IPO Year
- CYBR 2014
- HOLX 1990
- Fundamental
- Price
- CYBR $352.22
- HOLX $69.73
- Analyst Decision
- CYBR Strong Buy
- HOLX Buy
- Analyst Count
- CYBR 30
- HOLX 14
- Target Price
- CYBR $349.53
- HOLX $88.92
- AVG Volume (30 Days)
- CYBR 469.2K
- HOLX 2.7M
- Earning Date
- CYBR 02-13-2025
- HOLX 02-05-2025
- Dividend Yield
- CYBR N/A
- HOLX N/A
- EPS Growth
- CYBR N/A
- HOLX 81.42
- EPS
- CYBR 0.29
- HOLX 3.32
- Revenue
- CYBR $909,462,000.00
- HOLX $4,030,300,000.00
- Revenue This Year
- CYBR $34.59
- HOLX $5.40
- Revenue Next Year
- CYBR $31.32
- HOLX $5.74
- P/E Ratio
- CYBR $1,381.40
- HOLX $21.00
- Revenue Growth
- CYBR 30.31
- HOLX N/A
- 52 Week Low
- CYBR $223.09
- HOLX $68.61
- 52 Week High
- CYBR $363.00
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- CYBR 66.15
- HOLX 34.61
- Support Level
- CYBR $331.64
- HOLX $68.61
- Resistance Level
- CYBR $345.00
- HOLX $72.99
- Average True Range (ATR)
- CYBR 10.38
- HOLX 1.52
- MACD
- CYBR 1.38
- HOLX -0.09
- Stochastic Oscillator
- CYBR 79.27
- HOLX 19.02
About CYBR CyberArk Software Ltd.
CyberArk is a cybersecurity vendor focused on the identity market. The company's core privileged access management offering is a market leader within that subsegment, with more than half of the Fortune 500 CyberArk customers. The identity security vendor was founded in 1999 and has around 9,000 customers across various industries. While historically, CyberArk has sold its security solutions primarily via on-premises licenses, over the past few years, it has transitioned to a subscription, recurring revenue model.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.